Evidence map›Paper›PMID 30079579›Full record

ArticleInternational wound journal2018

Impact of Gram-negative bacteria on the treatment of venous leg ulcers.

Wibke L Engelberg, Martin Dörler, Markus Stücker, Stefanie Reich-Schupke

Open access · greenAbstract read
In one paragraph

Article in International wound journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Wibke L EngelbergKlinik für Dermatologie, Venerologie und Allergologie, Ruhr-Universität Bochum, Bochum, Germany.
Martin DörlerKlinik für Dermatologie, Venerologie und Allergologie, Ruhr-Universität Bochum, Bochum, Germany.
Markus StückerKlinik für Dermatologie, Venerologie und Allergologie, Ruhr-Universität Bochum, Bochum, Germany.
Stefanie Reich-SchupkeKlinik für Dermatologie, Venerologie und Allergologie, Ruhr-Universität Bochum, Bochum, Germany.
Ruhr University Bochum · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gram-negative germs with and without multi-resistance are garnering more and more importance. The aim of this study was to investigate the frequency and rate of resistance against antibiotics and to clarify the impact of Gram-negative bacteria, especially with high rates of resistance, for the treatment of venous leg ulcers. This is a retrospective, monocentric, non-randomised open study. Included were all data within 1 year of bacterial swabs of venous leg ulcers. We performed summarization, pooling, and descriptive analysis for frequencies and crossover. We analysed 679 swabs of 285 patients with venous leg ulcers. The mean patient age was 69.78 years. There were 76.1% Gram-positive and 58.2% Gram-negative germs detected; 56.5% of the swabs showed multi-resistance. Gram-negative bacteria were associated with more pain. Exacerbation and relevant aggravation of wounds that led to stationary treatment occurred more frequently. With polihexanid treatment, we saw less Gram-negative flora. This study showed an immediate impact of Gram-negative germs on the patient's pain, the risk for aggravation, and the choice of treatment. Further studies for prophylaxis and treatment of Gram-negative germs in venous leg ulcer therapy are needed.

Indexed as

AdultAgedAged, 80 and overAnti-Bacterial AgentsFemaleGram-Negative BacteriaGram-Negative Bacterial InfectionsHumansLeg UlcerMaleMiddle AgedRetrospective StudiesVaricose UlcerWound HealingYoung AdultAnti-Bacterial Agentsbacterial swabgram-negative germsmulti-resistancepainvenous leg ulcer

Identifiers

PMID30079579
PMCPMC7949991
OpenAlexW2886204129

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.